Switzerland-based CARBOGEN AMCIS achieves ANVISA GMP certification for Shanghai facility
In a significant achievement for Switzerland-based CARBOGEN AMCIS, a leading name in pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing, the company announced its successful clearance of the Brazilian Regulatory Authority Agency (ANVISA) routine inspection at its Shanghai facility. Conducted from November 6 to 10, 2023, the five-day inspection concluded with the granting of […]